CENTRAL-NERVOUS-SYSTEM DISORDERS AND POSSIBLE BRAIN-TYPE CARNITINE PALMITOYLTRANSFERASE-II DEFICIENCY

Citation
Y. Ohtani et al., CENTRAL-NERVOUS-SYSTEM DISORDERS AND POSSIBLE BRAIN-TYPE CARNITINE PALMITOYLTRANSFERASE-II DEFICIENCY, Brain & development, 16(2), 1994, pp. 139-145
Citations number
28
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
03877604
Volume
16
Issue
2
Year of publication
1994
Pages
139 - 145
Database
ISI
SICI code
0387-7604(1994)16:2<139:CDAPBC>2.0.ZU;2-U
Abstract
We describe two male infants with central nervous system disorders, i. e. infantile spasms in one and athetotic quadriplegia in the other, an d with recurrent attacks of high plasma creatine kinase levels induced by viral infections. Although carnitine palmitoyltransferase I (CPT I ) activity in biopsied muscle was normal in both cases, that of carnit ine palmitoyltransferase II (CPT II) was decreased to 37% and 25% of t he control value, respectively. Meanwhile, to determine whether or not and how CPT exists in the central nervous system (CNS), we studied an imal brain tissues. CPT activity was demonstrated in almost all region s, especially in the brainstem, cerebellum and spinal cord. Although C PT deficiency can be classified into hepatic (CPT I) and muscular (CPT II) presentations, these data suggest that another symptomatology of CPT II deficiency with CNS involvement (brain type?) might exist.